HEALTH● LOWSep 9 · Sep 9, 2026, 2:17 PM
Semaglutide Tied to 21% Fewer Psychiatric Stays in Bipolar Swedes
Human Progress · western europe
“Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization.” From ScienceDaily. The post Semaglutide Tied to Psychiatric Benefits for Bipolar Swedes appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH23m agoPope Leo XIV has 'good night' in hospital after lung surgery, Vatican saysEuroNews [en]HEALTH41m agoWHO Urges Action On Lead Poisoning DangersChannels TVHEALTH44m agoPublic warned of poisonous mushrooms resembling edible varietiesJapan TodayHEALTH46m ago'Spain's hallmark in Vatican': The Spanish medical science behind Pope Francis' lung operationEuroNews [en]